Latest news
Structure Therapeutics (GPCR) Is Up 10.6% After Advancing Oral Obesity Drug Into Phase 3 Trial - simplywall.stsimplywall.st · Sat, 08 Aug 2026 17:32:25 GMTBofA points to the Eli Lilly market that could outsize the U.S. - thestreet.comthestreet.com · Sat, 08 Aug 2026 15:33:00 GMTBelly Fat and Low Vitamin D May More Than Double the Risk of Early Death - SciTechDailySciTechDaily · Sat, 08 Aug 2026 15:21:13 GMTUncovering the Metabolic Origins of Polycystic Ovary Syndrome - CureusCureus · Sat, 08 Aug 2026 14:26:24 GMTRevealed: Scale of obesity drug misuse in sport - The TimesThe Times · Sat, 08 Aug 2026 11:05:47 GMTComparison of Lifestyle Factors, Dietary Intake, and Physical Activity Among Female Chinese University Students With and Without Normal Weight Obesity - CureusCureus · Sat, 08 Aug 2026 07:51:28 GMTGLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Sat, 08 Aug 2026 04:39:05 GMTRise in heart disease linked to obesity and diabetes - WDIO.comWDIO.com · Sat, 08 Aug 2026 02:30:19 GMT